Ципробай

Ципробай – the synthetic medicine suppressing bacterial activity of gram-negative bacteria during division and rest and gram-positive microorganisms during division. Reviews of Tsiprobaye testify to speed and high medical performance of an antibiotic.

Tsifran, Tsiprinol, Tsipromed, Sifloks, Tatsil, Neofloksin, Proksatsin, Tsipronat, Tsipromed, Tsiprobrin, Medotsiprin, Ifitsipro carry to analogs of Tsiprobaya.

Structure and form of release of Tsiprobaya

Ципробай make in the following forms:

• in the form of tablets, coated 100 mg, 250 mg, 500 mg.
• in the form of 1% solution for injections;
• in the form of 0,2% solution for infusions;
• in the form of syrup (100 mg).

Ciprofloxacin – the main operating antibiotic component.

One tablet of medicine of Tsiprobay contains 250 mg of ciprofloxacin.

Pharmacological action

The main active ingredient of Tsiprobaya interferes with growth and active division of bacteria, promotes disturbance of their cellular structure that leads to death of microorganisms. Resistance of microorganisms to drug of Tsiprobay develops very slowly: after effect of the medicine there is practically no persistent bacterium left, besides bacterial cells have no special enzymes capable to inactivate ciprofloxacin in Tsiprobaye. In acid medium activity of an antibiotic of Tsiprobay significantly decreases.

Indications to use of Tsiprobaya

Indications to use of Tsiprobaya are the complicated and uncomplicated infectious diseases caused by the organisms sensitive to the main substance of an antibiotic:

• infectious diseases of a respiratory organs (bronchitis, mucoviscidosis, pneumonia);
• infectious diseases of ENT organs (antritis, tonsillitis, pharyngitis, sinusitis, frontal sinusitis, mastoiditis);
• infectious processes in soft tissues (contaminated wounds, burns, ulcers, abscesses);
• infections of joints and bones (osteomyelitis, sepsis, septic arthritis);
• infections of generative organs (clamidiosis, gonorrhea, prostatitis, adnexitis);
• infectious diseases of an abdominal cavity (GIT infections, peritonitis, typhoid, cholera, salmonellosis, infections of a gall bladder);
• infections of urinary tract and kidneys (pyelonephritis, cystitis);
• infections of eyes (the blepharitis, blefarokonjyunktivit, a keratitis, etc.);
• infections against the background of a neutropenia and an immunodeficiency;
• prevention and treatment of a malignant anthrax at children.

Contraindications to use of Tsiprobaya

• hypersensitivity to ciprofloxacin or other substances of group of hinolon;
• children's and teenage age (an exception – infections of lungs);
• pregnancy and period of breastfeeding;
• individual intolerance of any component of medicine;
• simultaneous use of a tizanidin and ciprofloxacin.

Routes of administration

The recommended doses of Tsiprobaya according to the instruction following:

• infectious processes of respiratory tracts: in the form of tablets – 250-500 mg twice a day or intravenously in the form of infusion solution – 200-400 mg two times a day;
• acute, uncomplicated infections of urinary tract – on 125 mg two times per day in the form of tablets or intravenously on 125 mg twice a day;
• the complicated infections of urinary tract – 250-500 mg twice a day in the form of tablets or 100 mg twice a day in the form of infusion solution intravenously;
• other infections – on 500 mg two times a day or intravenously 200-400 mg twice a day in the form of infusion solution;
• especially heavy infections (with threat for life) – 750 mg twice a day in the form of tablets or on 400 mg three times a day in the form of infusion solution intravenously;
• treatment and prevention of a pulmonary form of a malignant anthrax at children – 20 mg/kg of body weight 2 times per day or intravenously 10 mg/kg of body weight three times a day.

Pill of Tsiprobay according to the instruction is recommended to take on an empty stomach, washing down with water. Intravenously solution is recommended to enter very slowly (about 60 minutes) for prevention of development of complications in the place of infusion.

Medical therapy can continue from 1 to 60 days. The way and duration of treatment by drug depends on a form of a disease and weight of a condition of the patient. Treatment by drug of Tsiprobay according to the instruction is recommended to be continued within three-four days after disappearance of all clinical symptoms of a disease.

Side effect of Tsiprobaya

Reviews of Tsiprobaye demonstrate that drug can make sick, vomiting, dizziness, diarrhea, allergic reactions, confusion of consciousness, concern. Use of Tsiprobaya in treatment can lead to decrease in the ABP, emergence of arrhythmia and tachycardia, throat hypostasis, диспноэ, to a sonitus, disturbance of taste, sight and color perception. Occasionally prolonged use of an antibiotic can lead to hemolitic disturbances and to disturbance of chemical composition of urine, a necrosis of a liver, a myasthenia, a rupture of sinews, pancreatitis, a vasculitis, an acute anaphylaxis, development of a syndrome of Stephens-Johnson, a Lyell's disease.

Precautionary measures

Ципробай with care appoint at epilepsy, heavy abnormal liver functions, kidneys and TsNS, defeat of vessels, old age. At purpose of an antibiotic it is necessary to remember that its action can influence the speed of psychomotor reactions.